Home » Topics » Conferences

Conferences
RSS

Potent non-HAP class I HBV capsid assembly modulator ALG-005398 reduces HBsAg levels in vivo

Nov. 22, 2021

AL-009 shows antitumor efficacy both as monotherapy and in combination with anti-PD-L1

Nov. 22, 2021

NTX-1088, anti-PVR MAb with exclusive triple mechanism of action

Nov. 22, 2021

LINC01348 as a potential new therapeutic target and biomarker in HCC

Nov. 22, 2021

In vivo studies of HRX-0215 in acute and chronic liver disease

Nov. 22, 2021

ALP and LECT2 are markers of SZN-043 target engagement and Wnt pathway activation

Nov. 22, 2021

Researchers develop new model of heart failure with preserved ejection fraction

Nov. 19, 2021

A-2342: a highly potent, selective, orally available NTCP inhibitor

Nov. 19, 2021

SGN-PDL1V, a PD-L1-directed ADC with activity in multiple tumor xenograft models

Nov. 19, 2021

Antibody-drug conjugate SGN-B7H4V shows promise in preclinical models of cancer

Nov. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...